Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1994 • 2,529 citations

Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

1981 • 1,281 citations

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1982 • 1,001 citations

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1994 • 934 citations

The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas

1984 • 922 citations

Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines

1994 • 841 citations

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1991 • 619 citations

Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors

1992 • 551 citations

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

1994 • 522 citations

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

1995 • 446 citations

A clinical trial of anti-idiotype therapy for B cell malignancy

1985 • 434 citations

A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3

1994 • 379 citations

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1993 • 314 citations

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.

1995 • 296 citations

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes.

1995 • 282 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

1988 • 239 citations

Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2

1978 • 239 citations

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

1982 • 237 citations

Mouse × human heterohybridomas as fusion partners with human B cell tumors

1986 • 171 citations

Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.

1987 • 168 citations

Cell-Mediated Immunity to Varicella-Zoster Virus

1992 • 158 citations

Recognition and destruction of virus-infected cells by human gamma delta CTL.

1994 • 158 citations

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

1980 • 152 citations

In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein.

1994 • 150 citations

Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

1992 • 132 citations

Prolonged Survival for Melanoma Patients With Elevated IgM Antibody to Oncofetal Antigen<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>

1981 • 126 citations

Immune response to a carcinoembryonic antigen polynucleotide vaccine.

1994 • 121 citations

Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection.

1994 • 106 citations

Antiviral Cytotoxic T Lymphocyte Induction and Vaccination

1988 • 98 citations

Active Specific Immunotherapy of Melanoma with Allogeneic Cell Lysates Rationale, Results, and Possible Mechanisms of Actiona

1993 • 97 citations

Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.

1989 • 95 citations

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide.

1994 • 82 citations

The Role of Idiotype-Specific, CD4+ T Cells in Tumor Resistance against Major Histocompatibility Complex Class II Molecule Negative Plasmacytoma Cells

1993 • 81 citations

Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo.

1992 • 78 citations

Therapy of lymphoma directed at idiotypes.

1990 • 73 citations

Influenza: pathogenesis and host defense.

1992 • 71 citations

Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

1994 • 71 citations

Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.

1987 • 66 citations

Cytotoxic T-Cell Response and In Vivo Protection Against Tumor Cells Harboring Activated ras Proto-oncogenes

1993 • 66 citations

Gamma delta T cell recognition of tumor Ig peptide.

1995 • 64 citations

Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine

1995 • 62 citations

Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line

1982 • 62 citations

Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.

1994 • 61 citations

Direct analysis of tumor-associated peptide antigens

1994 • 60 citations

Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation.

1983 • 58 citations

Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles

1994 • 54 citations

Therapeutic Reconstitution of Human Viral Immunity by Adoptive Transfer of Cytotoxic T Lymphocyte Clones

1994 • 47 citations

Clinical Trials of Idiotype-Specific Vaccine in B-Cell Lymphomas

1993 • 45 citations

Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T‐cell receptor: Limiting dilution analysis of specific CTLp in peripheral blood and tumor‐invaded lymph nodes of melanoma patients

1994 • 45 citations

Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)

1994 • 42 citations

Cell-Mediated Immune Responses of Breast Cancer Patients to Autologous Tumor-Associated Antigens2

1977 • 39 citations

Immunogenicity and Clinical Activity of a Polyvalent Melanoma Antigen Vaccine Prepared from Shed Antigensa

1993 • 36 citations

Human T cells in hu-PBL-SCID mice proliferate in response to Daudi lymphoma and confer anti-tumour immunity

1994 • 32 citations

Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina.

1995 • 31 citations

Development of a New Therapeutic Approach to B Cell Malignancy. The Induction of Immunity by the Host Against Cell Surface Receptor on the Tumor

1989 • 30 citations

The Class I-Restricted Cytotoxic T Lymphocyte Response to Predetermined Epitopes in the Hepatitis B and C Viruses

1994 • 30 citations

Human cytotoxic T-lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion

1992 • 28 citations

A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patients.

1994 • 27 citations

Cytotoxic T Lymphocyte Responses Against Measles Virus

1994 • 22 citations

Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.

1994 • 20 citations

Anti-Idiotype Vaccine in Colorectal Cancer Patients

1993 • 20 citations

Immunotherapeutic Strategies for Cancer Using Poxvirus Vectors

1993 • 17 citations

Human Immune Response to DNP-Modified Autologous Cells after Treatment with a DNP-Conjugated Melanoma Vaccine

1995 • 17 citations

Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.

1995 • 17 citations

The Cytotoxic T-Lymphocyte Response in HIV-1 Infection

1994 • 16 citations

Cytotoxic T Lymphocytes

2005 • 15 citations

Primary cytotoxic T lymphocyte induction using peptide-stripped autologous cells

1994 • 14 citations

Cytotoxic T lymphocytes and immune surveillance.

1992 • 13 citations

Protective Cellular Immunity against a Spontaneous Mammary Carcinoma from ras Transgenic Mice

1994 • 9 citations

Novel tumor-associated accessory molecules involved in the gamma/delta cytotoxic t-lymphocyte-Burkitt's lymphoma interaction

1995 • 5 citations

Unconventional cytotoxic T lymphocyte recognition of synthetic peptides corresponding to residues 1—23 of Ras protein

1994 • 4 citations